Please try another search
For the six months ended 30 June 2018, Changsheng Bio-technology Co Ltd revenues increased 9% to RMB688.4M. Net income decreased 5% to RMB252.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Selling Expense increase of 30% to RMB238.4M (expense), General & Administrative Expenses increase of 73% to RMB116.1M (expense).
Period Ending: | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 |
---|---|---|---|---|
Total Revenue | 342.06 | 346.37 | 410.06 | 513.52 |
Gross Profit | 302.12 | 315.06 | 361.32 | 441.64 |
Operating Income | 116.99 | 186.2 | 152.19 | 202.83 |
Net Income | 94.84 | 157.25 | 129.87 | 172.15 |
Period Ending: | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 |
---|---|---|---|---|
Total Assets | 4383.53 | 4684.17 | 4510.27 | 4309.06 |
Total Liabilities | 638.02 | 670.21 | 653.56 | 594.82 |
Total Equity | 3745.51 | 4013.96 | 3856.71 | 3714.24 |
Period Ending: | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 |
---|---|---|---|---|
Period Length: | 6 Months | 3 Months | 12 Months | 9 Months |
Cash From Operating Activities | 243.47 | 87.38 | 485.89 | 187.75 |
Cash From Investing Activities | 79.56 | -218.41 | -384.9 | -82.18 |
Cash From Financing Activities | -389.48 | -262.5 | -235.6 | |
Net Change in Cash | -65.52 | -132.74 | -164.02 | -131.88 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review